Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
about
Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent mannerHoming in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosisEvolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsPromising Therapy Candidates for Liver FibrosisAdvances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their OriginControversies over the Epithelial-to-Mesenchymal Transition in Liver FibrosisCytoglobin as a Marker of Hepatic Stellate Cell-derived MyofibroblastsPotential Use of Biological Proteins for Liver Failure TherapyAnimal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentThe role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisHealing scars: targeting pericytes to treat fibrosisTherapeutic targeting of liver inflammation and fibrosis by nanomedicineBone marrow-derived fibrocytes contribute to liver fibrosisReversibility and heritability of liver fibrosis: Implications for research and therapyCulture Model of Rat Portal MyofibroblastsHigh-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers.Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activationMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.The Role of Mesothelial Cells in Liver Development, Injury, and RegenerationTargeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver FibrosisNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleElastin in the LiverStrategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferationEpithelial-mesenchymal transition in tissue repair and fibrosisGenetic tools for identifying and manipulating fibroblasts in the mousep62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver CancerLoss of pericyte smoothened activity in mice with genetic deficiency of leptin.Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in miceSerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells.The origin of fibrogenic myofibroblasts in fibrotic liver.The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis.Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinPlatelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosisIntegrins, myofibroblasts, and organ fibrosis.Origin of myofibroblasts in the fibrotic liver in mice
P2860
Q21999269-99C72C33-6928-4A3B-96E3-A3ACF17084B0Q26742049-806255A8-E416-4C75-8778-0A753A8DCA53Q26745566-A0641BDA-68E8-43C9-BD73-A32333384B14Q26766727-F301418A-01F4-40FB-91F2-C5E147100D15Q26769989-9197C115-7866-41D1-9558-F0B1213AA1F1Q26771108-F7EFAC12-BA20-4B0B-AAA1-E3FDE8677BC7Q26776162-0B72823E-CCD9-4152-89DE-FAB714A4F39FQ26781325-93BB207C-7FD5-44FE-87BE-728F8B009F85Q26781761-8930DADD-4B2C-4670-B4D4-5DD28871BCDDQ26797382-7FEA420D-912E-450E-B1A1-E0C2A0F5B9E4Q26825838-A1072348-5B47-475B-9BD9-C4DB635CC89FQ27000074-983C6D9E-1590-477C-A921-E60CF1F61B33Q27021576-CD049A30-E26B-4206-BD8D-15B6F0EC5E96Q27026622-5B7AE2C7-41E0-4C92-9D34-414614A4DCADQ27307866-4346A718-F65E-4C22-9DA9-E509F33AA6E3Q27310369-F942784C-1C03-4E32-9BF4-54F4E64A5426Q27347907-EF08AB9A-B878-4F5F-AB23-CEC0240E68EFQ27692609-BF863D3E-2F7F-41E5-BC94-ECFD47A628FBQ28066412-C800DC7F-B1BA-466F-B488-80EC6E63F5FAQ28070012-F420D0A5-7B67-4C2F-B66D-B96F606B2242Q28070168-9F07E2CA-83E6-4FE1-A07B-0E433EBE5FDDQ28077991-0EA18C52-65D0-40A2-B413-47AC69FC887EQ28082065-3AF2CD71-5170-46F1-9754-6D428F7D0A64Q28084572-7FEF1E35-F899-4127-9383-A5300D77F6D8Q28273742-A6D4318F-91B2-47F6-906F-31E7FD757468Q28388587-2F645F41-7594-4E40-B58C-67386072B6E4Q28392538-A5B286A1-AEB5-4651-B6CB-7C0B3D711E79Q29144909-A329ACE7-A1F3-4EF9-B68A-393EC68615C0Q33587672-1DEEB053-080E-4B7C-84C9-D04E9FD9C244Q33591426-1EBD489D-01DD-4095-B4F8-8ABCF36C96C9Q33722100-51B94917-49BE-4DE6-8413-6A5346DF1E88Q33774406-39B03289-1AF1-489A-A830-13B669CBA4DDQ33794042-53182847-F632-49FA-B48E-23B626FB1A2BQ33811966-BCFC3795-7377-44D2-B815-2BB8790975B0Q33818842-177530D5-C3DB-4972-B406-6421E6A7F0BBQ33826344-59F65D4B-C0A8-4304-8815-EB72157B6D1DQ33877800-D71D841E-D46E-489C-B5E1-2E6E8B235A1CQ33889261-ECBB8F34-BA92-4CA1-A0B2-B5B1B408DEA4Q33946587-599DB248-8E5A-4503-977C-FADEB7BE56C2Q34060761-F87B6474-1FCC-48B3-9186-44F4F144D578
P2860
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Fate tracing reveals hepatic s ...... independent of its aetiology.
@ast
Fate tracing reveals hepatic s ...... independent of its aetiology.
@en
type
label
Fate tracing reveals hepatic s ...... independent of its aetiology.
@ast
Fate tracing reveals hepatic s ...... independent of its aetiology.
@en
prefLabel
Fate tracing reveals hepatic s ...... independent of its aetiology.
@ast
Fate tracing reveals hepatic s ...... independent of its aetiology.
@en
P2093
P2860
P356
P1476
Fate tracing reveals hepatic s ...... s independent of its aetiology
@en
P2093
Christine C Hsu
Dianne H Dapito
Ingmar Mederacke
Juliane S Troeger
Robert F Schwabe
P2860
P2888
P356
10.1038/NCOMMS3823
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1038518975